triptolide has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Brincks, EL; Griffith, TS; James, BR; Kucaba, TA; Murphy, KA; Saluja, AK; Sangwan, V; Schwertfeger, KL | 1 |
| Huang, Y; Leng, T; Li, J; Qiu, P; Shu, M; Su, X; Xu, D; Yan, G; Zhu, W | 1 |
2 other study(ies) available for triptolide and Kidney Neoplasms
| Article | Year |
|---|---|
Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Diterpenes; Drug Synergism; Epoxy Compounds; Female; Humans; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Organophosphates; Phenanthrenes; Prodrugs; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Proteins; Specific Pathogen-Free Organisms; Survival Analysis; TNF-Related Apoptosis-Inducing Ligand; Tumor Burden | 2015 |
Triptolide-induced cell cycle arrest and apoptosis in human renal cell carcinoma cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Carcinoma, Renal Cell; Caspases; Cell Cycle; Cytochromes c; Diterpenes; Epoxy Compounds; Humans; Kidney Neoplasms; Mitochondria; Phenanthrenes; Tumor Cells, Cultured | 2011 |